Clinical Trial

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

Study acronym: LOLIPOP
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The LOLIPOP Trial is a large (n=4,300 patients) pragmatic, international, multicentre, prospective, randomised, double blind, placebo-controlled, parallel assessment, safety and effectiveness superiority study.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-07 -> 2028-05 2026-08-13
minor Completion pushed: 2028-07 -> 2029-05 2026-08-13
Trial Details
NCT Number NCT05072314
Lead Sponsor Monash University
Collaborators: Royal Perth Hospital
Conditions Breast Cancer, Breast Cancer Female, Breast Conserving Surgery, Mastectomy
Enrollment 4,300 participants
Start Date 2022-07-27
Primary Completion 2028-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-12